Radiology - Research Imaging Facilities
Director of its Cyclotron/PET Radiopharmaceutical Production Facility
The Mallinckrodt Institute of Radiology (MIR) at Washington University in St. Louis is recruiting a Director of its Cyclotron/PET Radiopharmaceutical Production Facility. This is a faculty position, with academic rank dependent upon qualifications.
The Cyclotron/PET Radiopharmaceutical Production Facility has been in existence since 1941, has four cyclotrons, and is one of the most advanced. It contains a Good Manufacturing Practices (GMP) Facility and a Radionuclide Production Laboratory (RPL). The GMP facility maintains a portfolio of over 20 human-use radiopharmaceuticals, and is the principal supplier of 18F-FDG to Barnes-Jewish Hospital (BJH), the flag-ship hospital of the Washington University School of Medicine. The RPL is the largest producer of Cu-64 in the world, used for local research and shipped for sale throughout the United States. The Facility also supports a large radiochemistry research initiative at Washington University, to include novel radiotracer development and first-in-human FDA trials.
The desired individual is a Ph.D. radiochemist or radiopharmacist with extensive experience in directing cyclotron radiochemistry production operations and standard and solid target production. A thorough understanding of Nuclear Regulatory Commission (NRC), Food and Drug Administration (FDA), United States Pharmacopeia (USP) and Nuclear Pharmacy regulations and standards is required. In addition to radiochemistry and production oversight, responsibilities include personnel and business operations management. Evidence of academic productivity is essential.
Mallinckrodt Institute of Radiology website: www.mir.wustl.edu
Pamela K. Woodard, M.D.
No end date
An Equal Opportunity Affirmative Action Employer
Washington University seeks an exceptionally qualified and diverse faculty; women, minorities, protected veterans and candidates with disabilities are strongly encouraged to apply.